Pregnancy outcome after TNF-α inhibitor therapy during the first trimester: a prospective multicentre cohort study

865 PIANO: A 1000 Patient Prospective Registry of Pregnancy Outcomes in Women With IBD Exposed to Immunomodulators and Biologic Therapy

(2015) Uma Mahadevan et al.   GASTROENTEROLOGY

THU0153 Pregnancy Outcomes in Women Exposed to the Tumor Necrosis Factor Inhibitor, Golimumab

(2014) A. Lau et al.   ANNALS OF THE RHEUMATIC DISEASES

Anti-TNFα Therapies Are Safe During Pregnancy in Women with Inflammatory Bowel Disease

(2014) Neeraj Narula et al.   INFLAMMATORY BOWEL DISEASES

Pregnancy Outcome After Methotrexate Treatment for Rheumatic Disease Prior to or During Early Pregnancy: A Prospective Multicenter Cohort Study

(2014) Corinna Weber-Schoendorfer et al.   Arthritis & Rheumatology

Safety of Anti-TNF Agents During Pregnancy and Breastfeeding in Women With Inflammatory Bowel Disease

(2013) Javier P Gisbert et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Safety of Thiopurines and Anti-TNF-α Drugs During Pregnancy in Patients With Inflammatory Bowel Disease

(2013) M J Casanova et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Safety of TNF-α inhibitors during IBD pregnancy: a systematic review

(2013) Ole Haagen Nielsen et al.   BMC Medicine

Limited Risks of Major Congenital Anomalies in Children of Mothers With IBD and Effects of Medications

(2013) Lu Ban et al.   GASTROENTEROLOGY

Pregnancy outcome following gestational exposure to TNF-alpha-inhibitors: A prospective, comparative, observational study

(2013) Orna Diav-Citrin et al.   REPRODUCTIVE TOXICOLOGY

Tumor necrosis factor-α inhibitor therapy and fetal risk: A systematic literature review

(2013) Renée M Marchioni   WORLD JOURNAL OF GASTROENTEROLOGY

Emerging data on the use of anti-tumor necrosis factor-alpha medications in pregnancy

(2012) Christina D. Chambers et al.   BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY

Placental Transfer of Anti–Tumor Necrosis Factor Agents in Pregnant Patients With Inflammatory Bowel Disease

(2012) Uma Mahadevan et al.   Clinical Gastroenterology and Hepatology

Syndactyly: phenotypes, genetics and current classification

(2012) Sajid Malik   EUROPEAN JOURNAL OF HUMAN GENETICS

High intra-uterine exposure to infliximab following maternal anti-TNF treatment during pregnancy

(2011) Z. Zelinkova et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

TNF-α and the Development of the Neonatal Immune System: Implications for Inhibitor Use in Pregnancy

(2011) Razvan Arsenescu et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

The role of teratology information services in screening for teratogenic exposures: Challenges and opportunities

(2011) Christina Chambers   AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS

Anti-TNF therapies and pregnancy: outcome of 130 pregnancies in the British Society for Rheumatology Biologics Register

(2011) S. M. M. Verstappen et al.   ANNALS OF THE RHEUMATIC DISEASES

The Distribution of Congenital Anomalies Within the VACTERL Association Among Tumor Necrosis Factor Antagonist-exposed Pregnancies Is Similar to the General Population

(2011) H. J. M. J. CRIJNS et al.   JOURNAL OF RHEUMATOLOGY

VACTERL/VATER Association

(2011) Benjamin D Solomon   Orphanet Journal of Rare Diseases

Case Report: Fatal case of disseminated BCG infection in an infant born to a mother taking infliximab for Crohn's Disease

(2010) Kuldeep Cheent et al.   Journal of Crohns & Colitis

European evidenced-based consensus on reproduction in inflammatory bowel disease

(2010) C. Janneke van der Woude et al.   Journal of Crohns & Colitis

Etanercept concentrations in maternal serum, umbilical cord serum, breast milk and child serum during breastfeeding

(2010) B. G. Berthelsen et al.   RHEUMATOLOGY

Kurzmitteilung zu den Perzentilwerten für die Körpermaße der Neugeborenen

(2010) M. Voigt et al.   ZEITSCHRIFT FUR GEBURTSHILFE UND NEONATOLOGIE

Women with rheumatoid arthritis negative for anti-cyclic citrullinated peptide and rheumatoid factor are more likely to improve during pregnancy, whereas in autoantibody-positive women autoantibody levels are not influenced by pregnancy

(2009) Y A de Man et al.   ANNALS OF THE RHEUMATIC DISEASES

Association of higher rheumatoid arthritis disease activity during pregnancy with lower birth weight: Results of a national prospective study

(2009) Ya��l A. de Man et al.   ARTHRITIS AND RHEUMATISM

Do Tumor Necrosis Factor Inhibitors Cause Malformations in Humans?

(2009) G. KOREN et al.   JOURNAL OF RHEUMATOLOGY

A Safety Assessment of Tumor Necrosis Factor Antagonists During Pregnancy: A Review of the Food and Drug Administration Database

(2009) J. D. CARTER et al.   JOURNAL OF RHEUMATOLOGY

Placental Transport of Immunoglobulins: A Clinical Review for Gastroenterologists Who Prescribe Therapeutic Monoclonal Antibodies to Women During Conception and Pregnancy

(2008) Sunanda V Kane et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

ORIGINAL ARTICLE: Treatment with Adalimumab (Humira®) and Intravenous Immunoglobulin Improves Pregnancy Rates in Women Undergoing IVF*

(2008) Edward E. Winger et al.   AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY

ORIGINAL ARTICLE: Treatment with Tumor Necrosis Factor Inhibitors and Intravenous Immunoglobulin Improves Live Birth Rates in Women with Recurrent Spontaneous Abortion

(2008) Edward E. Winger et al.   AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY

Using observational cohort data for studying drug effects on pregnancy outcome—Methodological considerations

(2008) Christof Schaefer et al.   REPRODUCTIVE TOXICOLOGY

Statistical methods for estimating the probability of spontaneous abortion in observational studies—Analyzing pregnancies exposed to coumarin derivatives

(2008) Reinhard Meister et al.   REPRODUCTIVE TOXICOLOGY